X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
antihypertensive agents - therapeutic use (11) 11
hypertension (11) 11
hypertension - drug therapy (11) 11
middle aged (10) 10
amlodipine - therapeutic use (9) 9
female (9) 9
male (9) 9
medicine, general & internal (9) 9
chlorthalidone - therapeutic use (8) 8
drug therapy (8) 8
aged (7) 7
blood-pressure (7) 7
double-blind method (7) 7
heart failure (7) 7
hypertension - complications (7) 7
lisinopril - therapeutic use (7) 7
prevention (7) 7
risk factors (7) 7
diuretics (6) 6
treatment outcome (6) 6
angiotensin-converting enzyme inhibitors - therapeutic use (5) 5
calcium channel blockers - therapeutic use (5) 5
cardiovascular diseases - epidemiology (5) 5
evaluation (5) 5
heart attack (5) 5
heart attacks (5) 5
hypertension - physiopathology (5) 5
index medicus (5) 5
mortality (5) 5
proportional hazards models (5) 5
antihypertensive drugs (4) 4
calcium channel blockers (4) 4
cardiovascular disease (4) 4
cardiovascular diseases - prevention & control (4) 4
clinical trials (4) 4
coronary disease - prevention & control (4) 4
diuretics - therapeutic use (4) 4
doxazosin - therapeutic use (4) 4
incidence (4) 4
lipid-lowering treatment (4) 4
myocardial infarction - prevention & control (4) 4
research (4) 4
therapy (4) 4
abridged index medicus (3) 3
cardiac & cardiovascular systems (3) 3
chlorthalidone (3) 3
clinical outcomes (3) 3
coronary disease - etiology (3) 3
doxazosin (3) 3
drug therapy, combination (3) 3
failure (3) 3
glomerular filtration rate (3) 3
heart failure - prevention & control (3) 3
hypolipidemic agents - therapeutic use (3) 3
patient outcomes (3) 3
peripheral vascular disease (3) 3
population (3) 3
progression (3) 3
risk (3) 3
ace inhibitors (2) 2
adverse and side effects (2) 2
african americans (2) 2
african continental ancestry group - statistics & numerical data (2) 2
allhat (2) 2
anticholesteremic agents (2) 2
blood pressure (2) 2
cardiac output (2) 2
cardiac output, low - etiology (2) 2
cardiovascular diseases (2) 2
cardiovascular events (2) 2
care and treatment (2) 2
chronic disease (2) 2
chronic kidney-disease (2) 2
converting-enzyme-inhibitor (2) 2
coronary disease - mortality (2) 2
design (2) 2
diabetes (2) 2
disease (2) 2
drugs (2) 2
enzymes (2) 2
health (2) 2
heart failure - epidemiology (2) 2
heart failure - etiology (2) 2
heart failure - mortality (2) 2
high blood-pressure (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2) 2
hypertension - ethnology (2) 2
hypertension - mortality (2) 2
hypertensive patients (2) 2
joint national committee (2) 2
kaplan-meier estimate (2) 2
kidney diseases - complications (2) 2
kidney diseases - physiopathology (2) 2
kidney failure, chronic - prevention & control (2) 2
lipids (2) 2
morbidity (2) 2
myocardial infarction - epidemiology (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - mortality (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 04/2005, Volume 293, Issue 13, pp. 1595 - 1608
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 02/2006, Volume 144, Issue 3, pp. 172 - 180
Journal Article
JAMA, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2981 - 2997
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 04/2000, Volume 283, Issue 15, pp. 1967 - 1975
CONTEXT Hypertension is associated with a significantly increased risk of morbidity and mortality. Only diuretics and β-blockers have been shown to reduce this... 
MEDICINE, GENERAL & INTERNAL | THERAPY | LEFT-VENTRICULAR MASS | FAILURE | Adverse and side effects | Doxazosin | Congestive heart failure | Risk factors | Hypertension | Cardiovascular disease | Heart attacks | Drug therapy
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 06/2012, Volume 7, Issue 6, pp. 989 - 1002
Background and objectives CKD is common among older patients. This article assesses long-term renal and cardiovascular outcomes in older high-risk hypertensive... 
AMERICAN | DESIGN | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | CHRONIC KIDNEY-DISEASE | ASSOCIATION | HYPERTENSIVE PATIENTS | PROGRESSION | Kidney Failure, Chronic - mortality | Myocardial Infarction - mortality | Humans | Middle Aged | Hypertension - drug therapy | Male | Incidence | Heart Failure - prevention & control | Lisinopril - therapeutic use | Time Factors | Myocardial Infarction - physiopathology | Hypertension - mortality | Heart Failure - etiology | Myocardial Infarction - etiology | Heart Failure - mortality | Chlorthalidone - therapeutic use | Glomerular Filtration Rate | Risk Assessment | Risk Factors | Kidney Diseases - mortality | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Canada | Stroke - etiology | Kidney Failure, Chronic - prevention & control | Hypolipidemic Agents - therapeutic use | Myocardial Infarction - prevention & control | Chronic Disease | Kidney Diseases - physiopathology | Multivariate Analysis | Puerto Rico | United States | Coronary Disease - mortality | Female | United States Virgin Islands | Kidney Diseases - complications | Stroke - mortality | Kidney - physiopathology | Severity of Illness Index | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Coronary Disease - etiology | Kidney Diseases - drug therapy | Treatment Outcome | Hypertension - physiopathology | Coronary Disease - prevention & control | Hypertension - complications | Kidney Failure, Chronic - etiology | Original
Journal Article
Journal Article
Hypertension, ISSN 0194-911X, 09/2006, Volume 48, Issue 3, pp. 374 - 384
The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) provides a unique opportunity to compare the long-term relative safety... 
Antihypertensive therapy | Heart failure | Stroke | Calcium channel blockers | Hypertension, detection and control | Angiotensin-converting enzyme | Cardiovascular diseases | MORTALITY | heart failure | calcium channel blockers | CARDIOVASCULAR EVENTS | OLDER ADULTS | ALLHAT | cardiovascular diseases | stroke | BLOOD-PRESSURE | antihypertensive therapy | MORBIDITY | DISEASE | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEALTH | ELDERLY-PATIENTS | hypertension, detection and control | angiotensin-converting enzyme | Blood Pressure | Cardiac Output, Low - epidemiology | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Risk | Gastrointestinal Hemorrhage - epidemiology | Incidence | Cardiac Output, Low - etiology | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Angioedema - etiology | Myocardial Infarction - etiology | Cardiovascular Diseases - etiology | Angioedema - epidemiology | Glomerular Filtration Rate | Coronary Disease - etiology | Hypertension - physiopathology | Amlodipine - therapeutic use | African Continental Ancestry Group - statistics & numerical data | Gastrointestinal Hemorrhage - etiology | Hypertension - ethnology | Hypertension - complications | Sex Distribution | Hypertrophy, Left Ventricular | Hypolipidemic Agents - therapeutic use | Myocardial Infarction - prevention & control | Blood Glucose - metabolism
Journal Article
Circulation, ISSN 0009-7322, 11/2008, Volume 118, Issue 22, pp. 2259 - 2267
Background-Heart failure (HF) developing in hypertensive patients may occur with preserved or reduced left ventricular ejection fraction (PEF [>= 50%] or REF... 
Angiotensin-converting enzyme inhibitors | Heart failure | Hypertension | Calcium channel blockers | Diuretics | Antihypertensive agents | Ventricular ejection fraction | heart failure | POPULATION | angiotensin-converting enzyme inhibitors | CARDIAC & CARDIOVASCULAR SYSTEMS | calcium channel blockers | PROGNOSIS | ALLHAT | antihypertensive agents | MECHANISMS | SYSTOLIC FUNCTION | PREVALENCE | DIASTOLIC DYSFUNCTION | CARDIOVASCULAR HEALTH | COMMUNITY | diuretics | ventricular ejection fraction | OLMSTED COUNTY | PERIPHERAL VASCULAR DISEASE | hypertension | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Prognosis | United States | Humans | Middle Aged | Adrenergic alpha-Antagonists - therapeutic use | Hypertension - drug therapy | Male | Coronary Disease - mortality | Heart Failure - prevention & control | Doxazosin - therapeutic use | Female | Hypertension - mortality | Heart Failure - epidemiology | National Heart, Lung, and Blood Institute (U.S.) | Double-Blind Method | Risk Assessment | Stroke Volume - physiology | Survivors | Stroke Volume - drug effects | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Coronary Disease - prevention & control | Survival Analysis | Hypertension - complications | Aged | Prevention | Care and treatment | Patient outcomes | Heart ventricle, Left | Physiological aspects | Antihypertensive drugs | Research | Cardiac output | Heart attack
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 22, pp. 2023 - 2031
Journal Article
Circulation, ISSN 0009-7322, 05/2006, Volume 113, Issue 18, pp. 2201 - 2210
Journal Article
Clinical Trials, ISSN 1740-7745, 08/2009, Volume 6, Issue 4, pp. 329 - 343
Journal Article